This evidence-based tool is composed of a series of questionnaires that assist clinicians in making person-centered cultural assessments to inform diagnosis and treatment planning.
The US is rapidly becoming a “majority minority nation,” since US census data predict that by 2044 non-Latino whites will account for less than 50% of the country’s population.1 These demographic shifts create a unique set of circumstances for health care institutions charged with providing high-quality services to diverse cultural groups and eliminating disparities in health care delivery.2 Meeting this challenge has become a major priority and policy focus for many local, state, and national organizations.3
The American Psychiatric Association (APA) and the DSM-5 Cross-Cultural Issues Subgroup (DCCIS) came together to produce and disseminate a tool at the vanguard of cultural psychiatric practice: the Cultural Formulation Interview (CFI).4 This evidence-based tool is composed of a series of questionnaires that assist clinicians in making person-centered cultural assessments to inform diagnosis and treatment planning.
What is culture?
At the core of the CFI is the definition of culture included in DSM-5:
Culture refers to systems of knowledge, concepts, rules, and practices that are learned and transmitted across generations. Culture includes language, religion and spirituality, family structures, life-cycle stages, ceremonial rituals, and customs, as well as moral and legal systems. Cultures are open, dynamic systems that undergo continuous change over time; in the contemporary world, most individuals and groups are exposed to multiple cultures, which they use to fashion their own identities and make sense of experience.4
Culture is therefore a multifactorial set of overlapping systems made up of many components beyond race and ethnicity, including not only the characteristics mentioned above but also gender identity, sexual orientation, and even generational cohort and occupational group. The views and practices associated with the confluence of these cultural characteristics affect how all participants in the health care process-patients and their relatives, as well as clinicians, administrators, and policy makers-understand illness and engage in care.
Evolution of the CFI
The CFI culminates decades of work by cultural psychiatrists and medical anthropologists who have sought to develop guidance for providers on the domains of assessment that would clarify the contribution of culture to the clinical encounter. The first iteration of this guidance came in DSM-IV (1994) as the Outline for Cultural Formulation (OCF) that described in narrative form the components of a cultural assessment-including, for example, the need to assess a patient’s cultural identity and cultural explanations of the illness.5 For the past 20 years, the OCF has been the most widely taught cultural assessment tool in mental health care. Semi-structured interviews, protocols, and questionnaires based on the OCF were developed, largely in Europe and North America, to facilitate its implementation by busy clinicians. Yet adoption of the OCF in routine clinical care remained limited.
The DCCIS sought to develop a consensus CFI-based on previous work operationalizing the OCF-that was feasible, acceptable, and clinically useful in daily practice. With the publication of DSM-5, the CFI is fast becoming the most widely used operationalized method for implementing the kind of cultural assessment described by the OCF.6 To achieve broad dissemination of the CFI, the APA provides it free.7
In collaboration with institutions from around the world, our team at Columbia University and the New York State Psychiatric Institute led a multidisciplinary consortium that developed and tested the CFI for DSM-5. More than 300 patients and 75 clinicians in 6 countries found the CFI to be feasible, acceptable, and clinically useful when incorporated at the beginning of a diagnostic evaluation.
The CFI facilitates the evocation of the patient’s own narrative of illness. In addition, it explicitly inquires about the views of members of the patient’s social network, to better place him or her in the context of a community and help the patient and his or her entourage engage more fully in the treatment process.
The CFI can be used in clinical encounters with all patients and all clinicians, not just with cultural minorities or in situations of obvious cultural difference between clinicians and patients. This is because all of us bring our own cultures, values, and expectations to the clinical encounter, including often invisible influences on how we approach specific aspects of care.
One example involves the sociocultural contexts of the clinical settings in which we work that we often take for granted. Psychiatrists may have differing sets of expectations and solutions when they shift from seeing new patients in an emergency department to more established patients in their private practice. While these are all clinical encounters, the cultures inherent to these medical practice settings differ vastly, and consequent alterations in practice style, priorities, and goals could result in meaningful changes in patient care.
Examples of these differences include expectations about payment for services, whether an interpreter is considered necessary, how the clinician takes into account the patient’s ability to follow a care plan, and whether relatives or other health systems are expected to be involved in care. The CFI can help bring into focus all of these cultural frameworks-including language and styles of communication, social supports, finances, and medical systems-and offer the opportunity to identify biases or synergies in care that may otherwise not be visible.
Components of the CFI
The CFI has 3 components. The first component is a core interview of 16 open-ended questions, with prompts for clinicians to understand the cultural content behind each question. It is divided into 4 domains (Figure):
• Cultural definition of the problem
• Cultural perceptions of cause, context, and support (including cultural identity)
• Cultural factors that affect self-coping and past help seeking
• Cultural factors that affect current help seeking
To help obtain collateral information (after consent is obtained from the patient or an authorized surrogate), a second, informant component of the CFI elicits the perspectives of persons closest to the patient, such as relatives, friends, and caregivers, on the same interview domains. This is particularly useful when the patient has decreased capacity (eg, is very young or has dementia or florid psychosis), and it can also provide ancillary information when patients prefer to involve significant others to help explain their priorities and enhance their care. If further information is desired, the third component consists of 12 supplementary modules that expand on the domains of the core and informant CFIs and can yield a more comprehensive cultural assessment.
CFI domains and clinical examples
The 4 domains of the core and informant CFI cover the main elements of a thorough cultural evaluation that can guide diagnosis and treatment planning in routine settings.
Domain 1: cultural definition of the problem. This domain seeks to incorporate the patient’s own view and language of his illness experience. The questions in this domain first inquire about the reasons for the visit, noting that the person’s understanding may be different from that of the provider. The CFI also asks about how these circumstances are described to people closest to the patient, noting that those explanations may differ from how the problem is described to the clinician. The rationale for the first 2 questions is that the way a problem is understood-whether it is defined as an illness-may take on many forms, and a person’s description of the situation may depend on the relationship with the interlocutor. These questions start to locate the person in the cultural context. The third question asks about the most troubling aspect of the problem. This helps clarify the day-to-day impact of the problem and helps focus treatment.
The value of this line of questioning may be illustrated by the situation of a homeless woman who appears to be responding to internal stimuli. Brought into an emergency department, she describes her problem as being “overwhelmed and unsure” and “unable to relax,” adding that the most troubling component is that she is always awake, looking around with worry, because of “sounds” that only she seems to notice. In sum, the main focus of her concern is that she cannot sleep because she is afraid.
This formulation of the problem comes much closer to the woman’s experience of her illness than a more technical focus on auditory hallucinations and paranoia. Her answers to the CFI evoke the reality of a person who lives on the streets without stable shelter and her consequent struggle for rest. These initial questions provide a framework for clinical humility regarding patients’ lived experience, helping to bridge the divide between concepts of “disease” used by medical experts and terms for “illness” that are closer to the experience of the person. Left unbridged, this divide can interfere with truly collaborative care.
Domain 2: cultural perceptions of cause, context, and support. The first set of questions in this domain aims to clarify what a person and his social network consider to be the origin of “the problem,” a key element of what Kleinman and colleagues8 called the “explanatory model.” For example, when a father responds to the informant CFI about the cause of his adolescent son’s crying spells and frequent school absences, he states that his son “has become trapped in the desires of the flesh and isn’t relying on God to shepherd him through the shadows of life. If he were only to pray and fast, he may find the comfort and redemption that only comes through faith and the cleansing power of sacrifice.”
This explanatory model is likely to be entirely different from that of the pediatric psychiatrist who diagnoses a biologically based major depression. The father’s narrative contributes critical information about the family’s dynamics and their views of sickness and identifies potential challenges to treatment that may have been missed if his viewpoint remained unexplored. Other questions in Domain 2 guide an interviewer in assessing what improves or worsens the problem, how the main aspects of the person’s cultural identity relate to the problem at hand, and whether the person’s background or identity is causing difficulties that may or may not be associated with this problem (eg, discrimination due to race/ethnicity or gender identity).
Domain 3: cultural factors that affect self-coping and past help seeking. This domain builds on Domain 2 to explore what the person has done in the past to cope by himself with the situation and to seek treatment or other forms of help (eg, advice), in light of the answers provided about stressors, supports, and cultural identity. An example is an African American man in his 20s who seeks treatment for substance abuse. His pri-mary self-identification is as a gay man-more than any other marker of culture-but this places him in a quandary.
His family and neighbors support his desire for sobriety but see homosexuality as unacceptable, whereas his friends are supportive of his sexual orientation but use drugs as a way of establishing intimacy and having fun. Drugs, for him, remain an important vehicle to social acceptance and away from personal isolation, despite his growing concern about his drug use. He has tried to reconcile these issues in the past by seeking an LGBT drug counseling program, but so far he has been unsuccessful.
Domain 4: cultural factors that affect current help seeking. This domain explores the person’s preferences for future care as well as those of his social network; it also addresses any concerns about the clinician-patient relationship. A useful scenario is that of an airline pilot who is a member of the Air National Guard and who has experienced anxiety attacks since the sudden death of her husband 1 year earlier. Initially, she thought she was coping well; now finds financial pressures and raising her 2 teenage sons to be highly challenging. She prefers cognitive-behavioral therapy because she worries that medications may disqualify her from flying. She is also concerned about revealing her thoughts to mental health professionals for fear that her squadron leaders may obtain a report of her treatment and may demand more details about her private life.
As these examples illustrate, the CFI ultimately seeks to help the clinician explore human suffering more fully. With each passing day, our world becomes more layered and complex. We are increasingly challenged to relate to one another across many languages, identities, practices, and traditions. These concerns take on even greater importance in health care and illness, when we are most vulnerable and in greatest need of being heard and understood. As we seek personalized and patient-centered medicine, the CFI is a powerful and evidence-based tool to ensure that clinical encounters remain focused on alleviation of suffering and, above all, remain human.
Dr DeSilva is Associate Director of Inpatient Psychiatry at Milstein Hospital, Columbia University Medical Center, in New York. Dr Aggarwal is Assistant Professor of Clinical Psychiatry at Columbia University College of Physicians and Surgeons and a Research Psychiatrist at New York State Psychiatric Institute in New York. Dr Lewis-FernÃ¡ndez is Professor of Psychiatry at Columbia University Medical Center and Director of the New York State Center of Excellence for Cultural Competence and the Hispanic Treatment Program at New York State Psychiatric Institute. Dr DeSilva reports that he is technical consultant to the Center of Excellence for Cultural Competence at the New York State Psychiatric Institute working on the New York State Office of Mental Health Cultural Formulation Interview Training Module; and he is the multimedia editor for the DSM-5 Handbook on the Cultural Formulation Interview. Dr Aggarwal reports that he has a grant from the NIMH for research on the Cultural Formulation Interview; he received royalties from a book about the Cultural Formulation Interview; and he is a consultant on the Cultural Formulation Interview for the New York State Office of Mental Health Center of Excellence for Cultural Competence at the New York Psychiatric Institute. Dr Lewis-FernÃ¡ndez reports that he is principal investigator of an investigator-initiated grant funded by Eli Lilly via Columbia University; and as the lead editor, he receives royalties from the DSM-5 Handbook on the Cultural Formulation Interview.
1. Colby SL, Ortman JM. Projections of the Size and Composition of the U.S. Population: 2014 to 2060. Current population reports, P25-1143. Washington, DC: US Census Bureau; 2014. https://www.census.gov/content/dam/Census/library/publications/2015/demo/p25-1143.pdf. Accessed May 15, 2015.
2. Brach C, Fraser I. Can cultural competency reduce racial and ethnic health disparities? A review and conceptual model. Med Care Res Rev. 2000;57(suppl 1):181-217.
3. Beach MC, Price EG, Gary TL, et al. Cultural competence: a systematic review of health care provider educational interventions. Med Care. 2005;43:356-373.
4. American Psychiatric Association. Cultural formulation. In: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Washington, DC: American Psychiatric Association; 2013:749-759.
5. American Psychiatric Association. Outline for cultural formulation. In: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994:845-846.
6. Lewis-FernÃ¡ndez R, Aggarwal NK, BÃ¤Ã¤rnhielm S, et al. Culture and psychiatric evaluation: operationalizing cultural formulation for DSM-5. Psychiatry. 2014;77(2):130-154.
7. American Psychiatric Association. Online Assessment Measures. http://www.psych.org/practice/dsm/dsm5/online-assessment-measures. Accessed May 11, 2015.
8. Kleinman A, Eisenberg L, Good B. Culture, illness, and care: clinical lessons from anthropologic and cross-cultural research. Ann Intern Med. 1978;88:251-258.